EYE PCR BV

Vision is a valuable gift to which we are committed to safeguard. Through persistent scientific research and our knowledge, we endeavor to provide innovation to the service of patients, significantly improving their everyday lives. Our Vision is to establish a renowned scientific environment building trust by providing science-based, high-tech innovation for the improvement and preservation of our most precious sense. We thrive at the intersection of innovation and health. Our mission: bring extraordinary science to life-changing therapies for patients with eye disorders. Established in 2018, led by pioneering inventors, EYE PCR ‘s primary objective is to develop a science-based, cutting- edge breakthrough that addresses the challenges in cataract and refractive lens exchange surgeries. Although the replacement of the human natural crystalline lens by an intraocular lens (IOL), to treat either cataract or Presbyopia is, at present, one of the most commonly performed procedures worldwide, a significant number of patients do not reach optimum vision. Through fixOflex™, EYE PCR incorporates innovation in conjunction with the extraordinarily successful method towards restorative intervention. fixOflexTM is a novel intraocular ophthalmic implant that was developed to "reconstruct" and hold the human lens capsule similar to its natural form to address the above-mentioned complications. fixOflex™ aims to more personalized care, tailored specifically to every single patient's needs, giving Ophthalmologists' the prospect for improvement to achieve optimal satisfaction.

• Employees 9
• Founded 2018